Antonio La Cava

Years Active: 2020-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Gianluca Moroncini, Silvia Svegliati, Antonella Grieco, Massimiliano Cuccioloni, Matteo Mozzicafreddo, Chiara Paolini, Silvia Agarbati, Tatiana Spadoni, Angela Amoresano, Gabriella Pinto, Qingxin Chen, Devis Benfaremo, Cecilia Tonnini, Martina Senzacqua, Silvia Alizzi, Karen Nieto, Doreen Finke, Nadia Viola, Donatella Amico, Mario Galgani, Stefano Gasparini, Lina Zuccatosta, Stefano Menzo, Martin Müller, Juergen Kleinschmidt, Ada Funaro, Antonio Giordano, Antonio La Cava, Peter Dorfmuller, Antonio Amoroso, Piero Pucci, Antonio Pezone, Enrico V Avvedimento, Armando Gabrielli
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis. Arthritis & rheumatology (Hoboken, N.J.) (2023)
Antonio La Cava
Low-dose interleukin-2 therapy in systemic lupus erythematosus. Rheumatology and immunology research 4 (3) (2023)
Aijing Liu, Fu-Dong Shi, Irun R Cohen, Giuseppe Castaldo, Giuseppe Matarese, Francisco J Quintana, Antonio La Cava
DNA vaccine encoding heat shock protein 90 protects from murine lupus. Arthritis research & therapy 22 (1) (2020)
Aijing Liu, Concetta Ferretti, Fu-Dong Shi, Irun R Cohen, Francisco J Quintana, Antonio La Cava
DNA Vaccination With Hsp70 Protects Against Systemic Lupus Erythematosus in (NZB × NZW)F1 Mice. Arthritis & rheumatology (Hoboken, N.J.) 72 (6) (2020)

Antonio La Cava.css-eqlu8i{font-size:small;padding-left:4px;}